Access the full text.
Sign up today, get DeepDyve free for 14 days.
K. Naruishi, F. Nishimura, Hisa Yamada-Naruishi, K. Omori, M. Yamaguchi, S. Takashiba (2003)
C-jun N-terminal kinase (JNK) inhibitor, SP600125, blocks interleukin (IL)-6-induced vascular endothelial growth factor (VEGF) production: cyclosporine A partially mimics this inhibitory effect.Transplantation, 76 9
J. Saris, F. Derkx, Jos Lamers, Pramod Saxena, M. Schalekamp, A. Danser (2001)
Cardiomyocytes Bind and Activate Native Human Prorenin: Role of Soluble Mannose 6-Phosphate ReceptorsHypertension: Journal of the American Heart Association, 37
G. Koehl, J. Andrassy, M. Guba, Sebastian Richter, A. Kroemer, M. Scherer, M. Steinbauer, C. Graeb, H. Schlitt, K. Jauch, E. Geissler (2004)
RAPAMYCIN PROTECTS ALLOGRAFTS FROM REJECTION WHILE SIMULTANEOUSLY ATTACKING TUMORS IN IMMUNOSUPPRESSED MICETransplantation, 77
M. Flather, S. Yusuf, L. Køber, M. Pfeffer, A. Hall, G. Murray, C. Torp-Pedersen, S. Ball, J. Pogue, L. Moye, E. Braunwald (2000)
Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patientsThe Lancet, 355
T. Waltman, T. Harris, D. Cesario, M. Ziegler, A. Maisel (1995)
Effects of enalapril on T and B cell function in rats after myocardial infarction.Journal of cardiac failure, 1 4
D. Griese, A. Ehsan, L. Melo, D. Kong, Lunan Zhang, M. Mann, R. Pratt, R. Mulligan, V. Dzau (2003)
Isolation and Transplantation of Autologous Circulating Endothelial Cells Into Denuded Vessels and Prosthetic Grafts: Implications for Cell-Based Vascular TherapyCirculation: Journal of the American Heart Association, 108
K. Jackson, S. Majka, Hongyu Wang, J. Pocius, C. Hartley, M. Majesky, M. Entman, L. Michael, K. Hirschi, M. Goodell (2001)
Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells.The Journal of clinical investigation, 107 11
S. Korom, I. Meester, T. Stadlbauer, A. Chandraker, M. Schaub, M. Sayegh, Alexander Belyaev, A. Haemers, S. Scharp, J. Kupiec-Weglinski (1997)
Inhibition of CD26/dipeptidyl peptidase IV activity in vivo prolongs cardiac allograft survival in rat recipients.Transplantation, 63 10
Tao Min, C. Zhu, Wang Xiang, Zhu Hui, S. Peng (2004)
Improvement in Endothelial Progenitor Cells from Peripheral Blood by Ramipril Therapy in Patients with Stable Coronary Artery DiseaseCardiovascular Drugs and Therapy, 18
A. Valenzuela-Fernández, T. Planchenault, F. Baleux, I. Staropoli, K. Le-Barillec, D. Leduc, T. Delaunay, F. Lazarini, J. Virelizier, M. Chignard, D. Pidard, F. Arenzana‐Seisdedos (2002)
Leukocyte Elastase Negatively Regulates Stromal Cell-derived Factor-1 (SDF-1)/CXCR4 Binding and Functions by Amino-terminal Processing of SDF-1 and CXCR4*The Journal of Biological Chemistry, 277
Alfred Kocher, M. Schuster, M. Szabolcs, S. Takuma, D. Burkhoff, Jie Wang, S. Homma, N. Edwards, S. Itescu (2001)
Neovascularization of ischemic myocardium by human bone-marrow–derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac functionNature Medicine, 7
G. Józefowicz-Okonkwo, A. Szmigielska-Kaplon, T. Robak (2002)
Cytotoxic effect of cyclosporin A alone and in combination with 2-chlorodeoxyadenosine against P388 murine leukemia in vivo.Medical science monitor : international medical journal of experimental and clinical research, 8 9
C. Herrera, C. Morimoto, J. Blanco, J. Mallol, Fernando Arenzana, C. Lluis, R. Franco (2001)
Comodulation of CXCR4 and CD26 in Human Lymphocytes*The Journal of Biological Chemistry, 276
C. Heeschen, R. Lehmann, Jörg Honold, B. Assmus, A. Aicher, D. Walter, H. Martin, A. Zeiher, S. Dimmeler (2004)
Profoundly Reduced Neovascularization Capacity of Bone Marrow Mononuclear Cells Derived From Patients With Chronic Ischemic Heart DiseaseCirculation: Journal of the American Heart Association, 109
S. Perry, Mijung Kim, G. Spangrude (1999)
Direct Effects of Cyclosporin a on Proliferation of Hematopoietic Stem and Progenitor CellsCell Transplantation, 8
C. Gerard, B. Rollins (2001)
Chemokines and diseaseNature Immunology, 2
K. Hiasa, M. Ishibashi, Kisho Ohtani, S. Inoue, Qingwei Zhao, S. Kitamoto, M. Sata, T. Ichiki, A. Takeshita, K. Egashira (2004)
Gene Transfer of Stromal Cell–Derived Factor-1&agr; Enhances Ischemic Vasculogenesis and Angiogenesis via Vascular Endothelial Growth Factor/Endothelial Nitric Oxide Synthase–Related Pathway: Next-Generation Chemokine Therapy for Therapeutic NeovascularizationCirculation: Journal of the American Heart Association, 109
F. Michel, M. Ambroisine, M. Duriez, C. Delcayre, B. Lévy, J. Silvestre (2004)
Aldosterone Enhances Ischemia-Induced Neovascularization Through Angiotensin II–Dependent PathwayCirculation: Journal of the American Heart Association, 109
T. Nagatsu, M. Hino, H. Fuyamada, T. Hayakawa, S. Sakakibara, Y. Nakagawa, T. Takemoto (1976)
New chromogenic substrates for X-prolyl dipeptidyl-aminopeptidase.Analytical biochemistry, 74 2
C. Wilasrusmee, I. Yusupov, P. Ondocin, D. Bruch, S. Kittur, S. Wilasrusmee, D. Kittur (2005)
Angiocidal effect of Cyclosporin A: a new therapeutic approach for pathogenic angiogenesis.International angiology : a journal of the International Union of Angiology, 24 4
Chao-Hung Wang, S. Verma, I. Hsieh, Agnes Hung, T. Cheng, Shin-Yi Wang, Yu-Chih Liu, W. Stanford, R. Weisel, Ren-Ke Li, W. Cherng (2007)
Stem Cell Factor Attenuates Vascular Smooth Muscle Apoptosis and Increases Intimal Hyperplasia After Vascular InjuryArteriosclerosis, Thrombosis, and Vascular Biology, 27
K. Christopherson, S. Cooper, H. Broxmeyer (2003)
Cell surface peptidase CD26/DPPIV mediates G-CSF mobilization of mouse progenitor cells.Blood, 101 12
B. Heissig, K. Hattori, S. Dias, M. Friedrich, B. Ferris, N. Hackett, R. Crystal, P. Besmer, D. Lyden, M. Moore, Z. Werb, S. Rafii (2002)
Recruitment of Stem and Progenitor Cells from the Bone Marrow Niche Requires MMP-9 Mediated Release of Kit-LigandCell, 109
D. Walter, K. Rittig, F. Bahlmann, R. Kirchmair, Marcy Silver, T. Murayama, Hiromi Nishimura, Douglas Losordo, T. Asahara, J. Isner (2002)
Statin Therapy Accelerates Reendothelialization: A Novel Effect Involving Mobilization and Incorporation of Bone Marrow-Derived Endothelial Progenitor CellsCirculation: Journal of the American Heart Association, 105
J. Yamaguchi, K. Kusano, O. Masuo, A. Kawamoto, Marcy Silver, S. Murasawa, M. Bosch-Marce, H. Masuda, Douglas Losordo, J. Isner, T. Asahara (2003)
Stromal Cell–Derived Factor-1 Effects on Ex Vivo Expanded Endothelial Progenitor Cell Recruitment for Ischemic NeovascularizationCirculation: Journal of the American Heart Association, 107
K. Christopherson, G. Hangoc, H. Broxmeyer (2002)
Cell Surface Peptidase CD26/Dipeptidylpeptidase IV Regulates CXCL12/Stromal Cell-Derived Factor-1α-Mediated Chemotaxis of Human Cord Blood CD34+ Progenitor Cells1The Journal of Immunology, 169
Zhenggang Zhang, Li Zhang, Q. Jiang, M. Chopp (2002)
Bone Marrow-Derived Endothelial Progenitor Cells Participate in Cerebral Neovascularization After Focal Cerebral Ischemia in the Adult MouseCirculation Research: Journal of the American Heart Association, 90
T. Asahara, T. Murohara, A. Sullivan, Marcy Silver, R. Zee, Tong Li, B. Witzenbichler, G. Schatteman, J. Isner (1997)
Isolation of Putative Progenitor Endothelial Cells for AngiogenesisScience, 275
Thomas Unger, T. Mattfeldt, V. Lamberty, Peter Bock, G. Mall, W. Linz, B. Scholkens, P. Gohlke (1992)
Effect of early onset angiotensin converting enzyme inhibition on myocardial capillaries.Hypertension, 20 4
T. Walther, A. Menrad, H. Orzechowski, G. Siemeister, M. Paul, M. Schirner (2003)
Differential regulation of in vivo angiogenesis by angiotensin II receptorsThe FASEB Journal, 17
Angus Mcquibban, G. Butler, J. Gong, L. Bendall, C. Power, I. Clark‐Lewis, Christopher Overall (2001)
Matrix Metalloproteinase Activity Inactivates the CXC Chemokine Stromal Cell-derived Factor-1*The Journal of Biological Chemistry, 276
H. Ikushima, Y. Munakata, T. Ishii, S. Iwata, M. Terashima, H. Tanaka, S. Schlossman, C. Morimoto (2000)
Internalization of CD26 by mannose 6-phosphate/insulin-like growth factor II receptor contributes to T cell activation.Proceedings of the National Academy of Sciences of the United States of America, 97 15
S. Verma, Chao-Hung Wang, Shu‐hong Li, A. Dumont, P. Fedak, M. Badiwala, B. Dhillon, R. Weisel, Ren-Ke Li, Donald Mickle, D. Stewart (2002)
A Self-Fulfilling Prophecy: C-Reactive Protein Attenuates Nitric Oxide Production and Inhibits AngiogenesisCirculation: Journal of the American Heart Association, 106
M. Guba, P. Breitenbuch, M. Steinbauer, G. Koehl, Stefanie Flegel, M. Hornung, C. Bruns, C. Zuelke, S. Farkas, M. Anthuber, K. Jauch, E. Geissler (2002)
Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factorNature Medicine, 8
S. Korom, I. Meester, A. Belyaev, G. Schmidbauer, K. Schwemmle (2003)
CD26/DPP IV in experimental and clinical organ transplantation.Advances in experimental medicine and biology, 524
Chao-Hung Wang, N. Ciliberti, Shu‐hong Li, P. Szmitko, R. Weisel, P. Fedak, M. Al-Omran, W. Cherng, Ren-Ke Li, W. Stanford, S. Verma (2004)
Rosiglitazone Facilitates Angiogenic Progenitor Cell Differentiation Toward Endothelial Lineage: A New Paradigm in Glitazone PleiotropyCirculation: Journal of the American Heart Association, 109
W. Waldman, A. Bickerstaff, G. Gordillo, K. Orosz, D. Knight, C. Orosz (2001)
Inhibition of angiogenesis-related endothelial activity by the experimental immunosuppressive agent leflunomide.Transplantation, 72 9
V. Bhattacharya, P. Mcsweeney, Q. Shi, B. Bruno, A. Ishida, R. Nash, R. Storb, L. Sauvage, W. Hammond, Moses Wu (2000)
Enhanced endothelialization and microvessel formation in polyester grafts seeded with CD34(+) bone marrow cells.Blood, 95 2
J. Lefebvre, L. Murphey, T. Hartert, Ru Shan, W. Simmons, N. Brown (2002)
Dipeptidyl Peptidase IV Activity in Patients With ACE-Inhibitor-Associated AngioedemaHypertension: Journal of the American Heart Association, 39
S. Korom, I. Meester, E. Maas, A. Stein, S. Wilker, F. Jung, R. Weimer, M. Brendel, W. Ernst, S. Friemann, R. Linder, H. Grimm, W. Padberg, S. Scharpe, J. Kupiec-Weglinski, K. Schwemmle (2002)
CD26 expression and enzymatic activity in recipients of kidney allografts.Transplantation proceedings, 34 5
S. Verma, M. Kuliszewski, Shu‐hong Li, P. Szmitko, L. Zucco, Chao-Hung Wang, M. Badiwala, Donald Mickle, R. Weisel, P. Fedak, D. Stewart, M. Kutryk (2004)
C-Reactive Protein Attenuates Endothelial Progenitor Cell Survival, Differentiation, and Function: Further Evidence of a Mechanistic Link Between C-Reactive Protein and Cardiovascular DiseaseCirculation: Journal of the American Heart Association, 109
K. Christopherson, S. Cooper, G. Hangoc, H. Broxmeyer (2003)
CD26 is essential for normal G-CSF-induced progenitor cell mobilization as determined by CD26-/- mice.Experimental hematology, 31 11
K. Christopherson, G. Hangoc, C. Mantel, H. Broxmeyer (2004)
Modulation of Hematopoietic Stem Cell Homing and Engraftment by CD26Science, 305
S. Papson (1981)
“Model”Humanity & Society, 5
Hao Wang, Karoline Hosiawa, B. Garcia, J. Shum, P. Dutartre, D. Kelvin, R. Zhong (2003)
Treatment with a short course of LF 15‐0195 and continuous cyclosporin A attenuates acute xenograft rejection in a rat‐to‐mouse cardiac transplantation modelXenotransplantation, 10
Yi-Chun Hsiao, Hsiao-Hui Chang, Ching-Yen Tsai, Y. Jong, L. Horng, Shu-fen Lin, T. Tsai (2004)
Coat color‐tagged green mouse with EGFP expressed from the RNA polymerase II promotergenesis, 39
R. Latini, G. Tognoni, A. Maggioni, M. Franzosi, E. Santoro, C. Baigent, Zhengming Chen, R. Collins, R. Peto, P. Sleight, E. Braunwald, M. Pfeffer, M. Flather, J. Kjekshus, L. Køber, Lisheng Liu, Wen Wang, F. Pizzetti, K. Swedberg, L. Tavazzi, S. Yusuf (2000)
Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin: systematic overview of individual data from 96,712 randomized patients. Angiotensin-converting Enzyme Inhibitor Myocardial Infarction CollabJournal of the American College of Cardiology, 35 7
Chao-Hung Wang, S. Verma, I. Hsieh, Yeung‐Jen Chen, L. Kuo, N. Yang, Shin-Yi Wang, Mei-Yun Wu, Chia-Ming Hsu, Chi-Wen Cheng, W. Cherng (2006)
Enalapril increases ischemia-induced endothelial progenitor cell mobilization through manipulation of the CD26 system.Journal of molecular and cellular cardiology, 41 1
(2002)
J Biol Chem
S. Kaushal, G. Amiel, K. Guleserian, O. Shapira, Tjorvi Perry, Fraser Sutherland, E. Rabkin, A. Moran, F. Schoen, A. Atala, S. Soker, J. Bischoff, J. Mayer (2001)
Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivoNature Medicine, 7
J. Fabre, A. Rivard, M. Magner, Marcy Silver, J. Isner (1999)
Tissue inhibition of angiotensin-converting enzyme activity stimulates angiogenesis in vivo.Circulation, 99 23
Cyclosporin A (CsA) improves the success rate of transplantation. The CD26/dipeptidylpeptidase IV (DPP IV) system plays a critical role in mobilizing endothelial progenitor cells (EPCs) from bone marrow. This study investigated whether CsA manipulates CD26/DPP IV activity and increases EPC mobilization. C57BL/6 mice were divided into control and CsA-treated groups. Before and after hindlimb ischemia was induced, circulating EPC number and serum levels of different cytokines were measured. Compared with the controls, CsA treatment significantly increased the blood levels of stroma-derived factor-1α and stem cell factor after ischemic stress ( P < 0.001). The CsA group displayed a significant increase in the number of circulating EPCs (sca-1 + KDR + and c-kit + CD31 + EPCs, both P < 0.05). In vivo, CsA caused a significant increase in the numbers of EPCs incorporated into the Matrigel and ischemic limbs ( P < 0.05). In the peripheral blood, CsA significantly decreased CD26 + cell numbers and attenuated the plasma CD26/DPP IV activity ( P < 0.001). Furthermore, short-term CsA treatment significantly improved the perfusion of ischemic limbs and decreased the spontaneous digital amputation rate. In summary, CsA manipulates the mobilization of EPCs into the circulation via the CD26/DPP IV system. Short-term CsA treatment has beneficial effects on angiogenesis of ischemic tissues. CD26/dipeptidylpeptidase IV Address for reprint requests and other correspondence: C.-H. Wang, Division of Cardiology, Dept. of Internal Medicine, Chang Gung Memorial Hospital, 222, Mai-Chin Road, Keelung, Taiwan (e-mail: bearty@adm.cgmh.org.tw )
AJP - Regulatory, Integrative and Comparative Physiology – The American Physiological Society
Published: Mar 1, 2008
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.